Skip to main content

Latest stock market podcasts

Part 2 Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 23 June

Jessica Amir
June 23, 2021

Morning Bell 22 June

Jessica Amir
June 22, 2021

Morning Bell 21 June

Jessica Amir
June 21, 2021

Weekly Wrap 18 June

Jessica Amir
June 18, 2021

Morning Bell 18 June

Jessica Amir
June 18, 2021

Morning Bell 17 June

Sophia Mavridis
June 17, 2021

Morning Bell 16 June

Jessica Amir
June 16, 2021

Morning Bell 15 June

Paulina Peters
June 15, 2021

Weekly Wrap 11 June

Jessica Amir
June 11, 2021

Morning Bell 11 June

Jessica Amir
June 11, 2021